25Jan

LifeMark Partners to Offer Cancer Genomic Profiling Program to More Than 2 million Americans

0 Comments | | Return |

LifeMark Partners, Inc., one of the nation’s largest independent national insurance marketing organizations, announced that a complimentary cancer genomic profiling program will be exclusively available to its partner broker general agents. The company says this is a first of its kind offer and will allow BGAs affiliated with LifeMark Partners to initially provide 250,000 Americans, who purchased new life insurance policies, with instant complimentary access for one year to Wamberg Genomic Advisors’ Cancer Guardian program. Cancer Guardian allows sequencing of a cancer tumor to learn about coding mutations that contribute to tumor progression.

 

Source: http://www.calbrokermag.com/insurance-insider-newsletter/chip-breathes-easy-for-a-bit/

Related

LifeMark Partners to Offer Every Consumer Complimentary Lifetime Subscriptions to LegacyShield

LegacyShield Solutions, Inc., the leader in providing the insurance and financial services industry ...

Read More >

LifeMark Partners and BRAMCO Financial Resources Unite to Form LIBRA Insurance Partners

LifeMark Partners and BRAMCO Financial Resources have joined forces to create LIBRA Insurance Partne...

Read More >

LifeMark Partners, Inc. Announces New Board Members

LifeMark Partners, Inc., one of the nation's largest independent national insurance marketing or...

Read More >

Congratulations to the 2019 Independent Distribution 20 Recipients!

New for 2019, the NAILBA ID 20 award will honor a diverse group of insurance professionals who are t...

Read More >

Life Distribution Has to Change: William Shelow Life Insurance Awareness Month

One thing that gives Shelow hope is that there appears to be plenty of room to improve.

Read More >

LifeMark Partners, Inc. First-Ever to Offer Cancer Genomic Profiling Program to More Than 2 million Americans

LifeMark Partners, Inc., one of the nation's largest independent national insurance marketing or...

Read More >